pageInfo({
    time : "1260959858793"
  
	    , page : null
	  
	    , url : null
	  
	    , instrument : null
	  
	    , article : {
	        storyId : "USLE47151020090714"
	        , headline : "REPEAT-UPDATE 1-Bayer, J&J to submit Xarelto data in Q4 earliest"
	        , keywords : "[Germany, Western Europe, Europe, Pharmaceuticals - diversified, Chemicals, Pharmaceuticals - generic and speciality, Pharmaceuticals (sub-industry), United States of America, Regulation and enforcement, France, Central and Eastern Europe, Healthcare, Pharmaceuticals and biotechnology, Business activities, Economic news, EC, business/financial pages]"
	        , tickers : "[us;SNYN, JNJ.N, jp;4863, mx;BMY, mx;JNJ, mx;PFE, PFE.N, SASY.PA, se;PFE, us;BAYZ, us;BMY, us;JNJ, us;PFE, us;SNY, it;SANF, gb;SNF, gb;PFZ, BMY.N, ch;JNJ, de;BAY, de;BRM, de;BRMF, de;BRMS, de;BRMX, de;JNJ, de;JNJF, de;JNJS, es;BAY, fr;SAN, gb;BYR, BAYG.DE]"
	    }
	    , channel : {
	        id : "1113"
	        , name : "rbssHealthcareNews"
	        , title : "Healthcare"
	    }})